BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 541368)

  • 1. Isolation by high-performance liquid chromatography and quantitation by radioimmunoassay of therapeutic concentrations of digoxin and metabolites.
    Nelson HA; Lucas SV; Gibson TP
    J Chromatogr; 1979 Jun; 163(2):169-77. PubMed ID: 541368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of digoxin, digitoxin, their cardioactive metabolites and derivatives by high-performance liquid chromatography and high-performance liquid chromatography-radioimmunoassay.
    Plum J; Daldrup T
    J Chromatogr; 1986 Apr; 377():221-31. PubMed ID: 3711211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of high-performance liquid chromatography and radioimmunoassay in the determination of content uniformity of digoxin tablets.
    Beasley MW; Skierkowski P; Cleary RW; Jones AB; Kibbe AH
    J Pharm Sci; 1983 May; 72(5):505-8. PubMed ID: 6864496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and quantitation of picomole quantities of digoxin, digitoxin and their metabolites by high-pressure liquid chromatography.
    Castle MC
    J Chromatogr; 1975 Dec; 115(2):437-45. PubMed ID: 1107340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of digoxigenin in serum following oral administration of digoxin in humans.
    Loo JC; McGilveray IJ; Jordan N
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):497-506. PubMed ID: 897341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic analysis of digoxin formulations.
    Desta B; McErlane KM
    J Pharm Sci; 1982 Jul; 71(7):777-80. PubMed ID: 7120061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac glycosides and metabolites--problems of recovery in tissue extracts. Separation of visible substance spots in the nanogram range (author's transl)].
    Aderjan R; Doster S; Petri H; Schmidt G
    Z Rechtsmed; 1979 Aug; 83(3):201-7. PubMed ID: 494819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of myocardial and serum digoxin concentrations in children by specific and nonspecific assay methods.
    Wagner JG; Dick M; Behrendt DM; Lockwood GF; Sakmar E; Hees P
    Clin Pharmacol Ther; 1983 May; 33(5):577-84. PubMed ID: 6839630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of tritiated digoxin and metabolites in urine by liquid chromatography.
    Eriksson BM; Tekenbergs L; Magnusson JO; Molin L
    J Chromatogr; 1981 May; 223(2):401-8. PubMed ID: 7251795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The question of cumulation of digoxin metabolites in renal failure.
    Gibson TP; Nelson HA
    Clin Pharmacol Ther; 1980 Feb; 27(2):219-23. PubMed ID: 7353343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of analysis of digoxin in cardiac patients by HPLC and RIA.
    Kwong E; Embree L; McErlane KM
    Res Commun Chem Pathol Pharmacol; 1990 Apr; 68(1):121-4. PubMed ID: 2345802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin and metabolites in urine and feces: a fluorescence derivatization--high-performance liquid chromatographic technique.
    Shepard TA; Hui J; Chandrasekaran A; Sams RA; Reuning RH; Robertson LW; Caldwell JH; Donnerberg RL
    J Chromatogr; 1986 Jul; 380(1):89-98. PubMed ID: 3745397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous analysis of digitoxin and its clinically relevant metabolites using high-performance liquid chromatography and radioimmunoassay.
    Santos SR; Kirch W; Ohnhaus EE
    J Chromatogr; 1987 Aug; 419():155-64. PubMed ID: 3667774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vivo evaluation of a radioimmunoassay and a chromatographic assay for the measurement of digoxin in biological fluids.
    Hinderling PH; Magnusson JO; Molin L
    J Pharm Sci; 1986 May; 75(5):517-21. PubMed ID: 3735093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reactivity of derivatives of digoxin and digitoxin as measured by the Na-K-atpase displacement assay and by radioimmunoassay.
    Marcus FI; Ryan JN; Stafford MG
    J Lab Clin Med; 1975 Apr; 85(4):610-20. PubMed ID: 123547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-positive digoxin measurements due to conjugated metabolite accumulation in combined renal and hepatic dysfunction.
    Vlasses PH; Besarab A; Lottes SR; Conner DP; Green PJ; Gault MH
    Am J Nephrol; 1987; 7(5):355-9. PubMed ID: 3324762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of digoxin at therapeutic concentrations using high-performance liquid chromatography with post-column derivatization.
    Kwong E; McErlane KM
    J Chromatogr; 1986 Sep; 381(2):357-63. PubMed ID: 3760091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of digoxin, digitoxin and their potential metabolites, impurities or degradation products by high-performance liquid chromatography.
    Desta B; Kwong E; McErlane KM
    J Chromatogr; 1982 May; 240(1):137-43. PubMed ID: 7096512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and estimation of endogenous digoxin in biological fluids and tissues by TLC and HPLC.
    Arun P; Ravikumar A; Leelamma S; Kurup PA
    Indian J Biochem Biophys; 1998 Oct; 35(5):308-12. PubMed ID: 10410465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.